Company intelligence / Profile preview
Polyneuron Pharmaceuticals AG
Basel, Basel-Stadt, Switzerlandorpha.net ↗
- Ownership
- Private
- Employees
- ~7
- Development stage
- Phase 1
01
Overview
Polyneuron Pharmaceuticals AG develops a new class of biodegradable glycopolymer-based therapeutics for antibody-mediated autoimmune diseases affecting the nervous system. Its lead candidate PN‑1007 targets anti-MAG neuropathy and has advanced to clinical trial-enabling studies with promising animal data and orphan drug designation from EMA. The company’s Antibody-Catch™ platform enables rational design of immunomodulatory compounds that selectively eliminate pathogenic autoantibodies while sparing normal immune function. Additional pipeline programs target motor neuron disease and complications related to hematopoietic stem cell transplantation.
- Therapeutic areas
- HematologyNeurology
- Modalities
- Glycopolymers (biodegradable glycopolymers)Small molecule drugs (as classified in some databases)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
University of Basel (academic collaboration)CTI-funded collaboration with University of Basel
Beyond the preview
Go deeper on Polyneuron Pharmaceuticals AG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Polyneuron Pharmaceuticals AG.